Company Encyclopedia
View More
name
GoodRx
GDRX.US
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. In addition, the company provides healthcare products and solution for dogs, cats, and other pets.
70.40 B
GDRX.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
Health Care TechnologyIndustry
Industry Ranking13/44
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE4.90%C
    • Profit Margin3.97%C
    • Gross Margin93.15%A
  • Growth ScoreC
    • Revenue YoY1.30%C
    • Net Profit YoY295.78%A
    • Total Assets YoY-2.17%D
    • Net Assets YoY-13.74%E
  • Cash ScoreB
    • Cash Flow Margin2521.42%A
    • OCF YoY1.30%C
  • Operating ScoreB
    • Turnover0.6B
  • Debt ScoreC
    • Gearing Ratio54.68%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    GoodRx Holdings And 2 Other Promising Penny Stocks

    The U.S. stock market is rising, leading investors to explore penny stocks for potential high returns. This article highlights three promising penny stocks: GoodRx Holdings, Taboola.com, and Riskified. GoodRx offers tools to save on prescription drugs, Taboola.com operates an AI-based ad platform, and Riskified provides e-commerce risk intelligence. All three companies show strong financial health and growth potential, making them intriguing options for investors.

    Simplywall·
    US
    GDRX
    +0.36%
    US
    TBLA
    -1.49%
    US
    RSKD
    0.00%
    Simplywall·
    US
    GDRX
    +0.36%
    US
    TBLA
    -1.49%
    US
    RSKD
    0.00%

    Officer Nabiey Acquires 3,085 Of GoodRx Holdings Inc [GDRX]

    Nabiey Romin, an officer of GoodRx Holdings Inc, filed a Form 4 on November 17, 2025, disclosing ownership changes. On November 15, 2025, he exercised 4,804 shares and surrendered 1,719 shares at $2.97 each to cover option exercise costs and tax liabilities. His ending holdings are 156,492 shares directly.

    Reuters·
    US
    GDRX
    +0.36%
    Reuters·
    US
    GDRX
    +0.36%

    GoodRx Launches New $39 Per Month Weight Loss Telemedicine Subscription, Unveils Industry-Leading Introductory Cash Price of $199 Per Month for Ozempic® and Wegovy® | GDRX Stock News

    GoodRx has launched a new $39 per month telemedicine subscription for weight loss, offering FDA-approved GLP-1 medications. In partnership with Novo Nordisk, GoodRx introduces an introductory cash price of $199 per month for Ozempic and Wegovy injection pens. This initiative aims to make weight management treatments more affordable and accessible, reinforcing GoodRx's leadership in medication savings.

    StockTitan·
    US
    GDRX
    +0.36%
    US
    NVO
    +0.88%
    StockTitan·
    US
    GDRX
    +0.36%
    US
    NVO
    +0.88%

    GoodRx Holdings, Inc. (NASDAQ:GDRX) Receives Average Rating of "Hold" from Analysts

    GoodRx Holdings, Inc. (NASDAQ:GDRX) has received a consensus rating of "Hold" from thirteen research firms. The average target price is $5.52, with one sell rating, six hold ratings, and six buy ratings. Recent analyst actions include Raymond James downgrading from "strong-buy" to "outperform" and Mizuho lowering the price target from $5.00 to $4.00. GoodRx's stock opened at $3.03, with a market cap of $1.05 billion. The company reported $0.08 EPS for the last quarter, missing estimates by $0.01, with revenue of $196.03 million, up 0.4% year-over-year.

    Market Beat·
    US
    GDRX
    +0.36%
    Market Beat·
    US
    GDRX
    +0.36%

    Other Drug Websites Such As GoodRx Won't Be Partnering With TrumpRx - CBS Reporter On X

    Goodrx Holdings Inc :OTHER DRUG WEBSITES SUCH AS GOODRX WON'T BE PARTNERING WITH TRUMPRX - CBS REPORTER ON X

    Reuters·
    US
    GDRX
    +0.36%
    Reuters·
    US
    GDRX
    +0.36%
    © 2025 Longbridge｜Disclaimer